Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electroacupuncture Modulates the Metabolism of SPMs and Ameliorates Respiratory Symptoms and Inflammation in Patients With Sepsis Complicating ARDS

NCT06006325 is registered in ClinicalTrials.gov with Tianjin Nankai Hospital as lead sponsor.

NCT NCT06006325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06006325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electroacupuncture Modulates the Metabolism of SPMs and Ameliorates Respiratory Symptoms and Inflammation in Patients With Sepsis Complicating ARDS
Lead sponsor
Tianjin Nankai Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
August 20, 2023
Completion date
October 2, 2024
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, sepsis